Myth: Prostate cancer screening reduces one’s mortality rate.
Truth: This is false. Studies show that increased screenings for prostate cancer could lead to overly aggressive treatments, financial concerns, and reduced patient quality of life. Furthermore, prostate cancer typically goes unnoticed as the onset of prostate cancer rarely displays symptoms. Some regular prostate cancer screeners also found no benefit in screening even after 10 years.
A study published in the journal Cancer examined whether if death rates caused by prostate cancer decreased due to increased prostate cancer screenings. Additionally, researchers examined whether the slight decrease in mortality outweighed consequences such as overtreatment. Researchers found no benefit in receiving routine, systematic prostate cancer screenings.
Read more about this article on prostate cancer and mortality by clicking here.